Cancer risk in children born after donor assisted reproductive technology

Autor: Williams, CL, Bunch, KJ, Murphy, MFG, Stiller, CA, Bottling, BJ, Wallace, WH, Davies, MC, Sutcliffe, AG
Rok vydání: 2017
Popis: Study question: Do children born after donor assisted reproductive technology (ART) have an increased risk of developing childhood cancer in comparison to the general population? Summary answer: This study showed no overall increased risk of childhood cancer in individuals born after donor ART. What is known already: Most large population based studies have shown no increase in overall childhood cancer incidence after non-donor ART; however other studies have suggested small increased risks in specific cancer types, including haematological cancers. Cancer risk specifically in children born after donor ART has not been investigated to date. Study design, size, duration: This retrospective cohort study utilized record linkage to determine the outcome status of all 12,186 children born in Great Britain (1992-2008) after donor ART. The cohort included 12,137 members contributed 95,389 person-years of follow-up (average follow-up 7.86 years). Participants, setting, methods: Records of all children born in Great Britain (England, Wales, Scotland) after all forms of donor ART (1992-2008) were linked to the UK National Registry of Childhood Tumours (NRCT) to determine the number who subsequently developed cancer by 15 years of age, by the end of 2008. Rates of overall and type specific cancer (selected a priori) were compared with age, sex and calendar year standardised population-based rates, stratifying for potential mediating/moderating factors including sex, age at diagnosis, birth weight, multiple births, maternal previous live births, assisted conception type, and fresh/ cryopreserved cycles. Main results and the role of chance: In our cohort of 12,137 children born after donor assisted reproductive technology (52% male, 55% singleton births), no overall increased risk of cancer was identified. There were 12 cancers detected compared to 14.4 expected (standardised incidence ratio (SIR) 0.83; 95% confidence interval (CI) 0.43-1.45; P=0.50). A small, significant increased risk of hepatoblastoma was found, but the numbers and absolute risks were small (
Databáze: OpenAIRE